The Lupus Foundation of America and investigators funded through the Foundation’s robust research grant programs will showcase new findings that offer important insights into lupus research and care ...
Fate Therapeutics announced promising preliminary clinical trial results for FT819, an investigational CAR T-cell therapy for ...
For Native American Heritage Month 2026, the Lupus Foundation of America (LFA) celebrates Native American people and their ...
In this episode of the Lupus Foundation of America's The Expert Series podcast, Dr. George Tsokos talks about the importance of individualized care and monitoring for effective management of lupus ...
A new study of adults with systemic lupus erythematosus (SLE) found those with mental health diagnoses (depression, anxiety, and posttraumatic stress disorder (PTSD)) have much higher repeat emergency ...
The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to EG-501 from Evergreen Therapeutics, an investigational oral treatment for adults with cognitive impairment associated ...
A new pooled analysis of adults with systemic lupus erythematosus (SLE) found commonly used patient-reported measures varied meaningfully in sensitivity to clinical changes in SLE, disease course and ...
The Expert Series is an educational podcast series featuring leading lupus experts with a focus on helping you live well with lupus. In each episode, lupus experts will offer invaluable insight on a ...
It is possible to get life insurance if you have lupus. However, there may be some challenges you'll need to prepare for. Because life insurance coverage is specific to each individual’s medical ...
The mission of the National Institutes of Health (NIH) is to develop the knowledge needed to prevent, detect, diagnose, and treat disease, illness, and disability. NIH employs some of the world’s most ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results